AI

The amount of health and "omics-related data" produced and stored has increased exponentially during the last few decades. In clinical trials, patient data can be gathered in real-time and examined using various artificial intelligence (AI) techniques; mobile devices can also be utilized to enhance certain facets o...

The Covid-19 pandemic has brought unprecedented challenges to the healthcare systems. Not just healthcare; in fact, the whole world came to a standstill. However, technology has played a crucial role in addressing some of the critical issues. The Covid-19 has accelerated the digital transformation and technological...

Artificial intelligence (AI) is the talk of the town. Though the term AI and its uses are not new, however, in the past few years there has been a phenomenal growth in AI research and its applications. Today, AI is making its way in almost every sector. Feeding on a large amount of data, AI can mimic human-like tas...

Biohaven buys PRV from GW Pharmaceuticals for USD 105 million GW Pharmaceuticals has announced its decision to sell its rare pediatric disease priority review voucher (PRV) to Biohaven Pharmaceuticals. The voucher was issued under U.S. Food and Drug Administration programme to accelerate speedy recovery of rare ...